GOLDMAN SACHS GROUP INC - SYROS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SYROS PHARMACEUTICALS INC's ticker is and the CUSIP is 87184Q206. A total of 55 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$420,801
+26.7%
106,532
+1.1%
0.00%–
Q2 2023$332,076
+18.2%
105,421
+0.2%
0.00%–
Q1 2023$280,969
+530.8%
105,232
+748.1%
0.00%–
Q4 2022$44,545–12,408–0.00%–
 Download
Other shareholders

There were no reported owners of SYROS PHARMACEUTICALS INC in Q2 2023.

NameSharesValueWeighting ↓
View complete list of SYROS PHARMACEUTICALS INC shareholders